Free Trial

Mesa Laboratories (MLAB) Stock Price, News & Analysis

Mesa Laboratories logo
$121.59 +0.12 (+0.10%)
(As of 12:36 PM ET)

About Mesa Laboratories Stock (NASDAQ:MLAB)

Key Stats

Today's Range
$120.00
$122.74
50-Day Range
$98.59
$135.91
52-Week Range
$83.68
$141.17
Volume
10,926 shs
Average Volume
41,272 shs
Market Capitalization
$660.23 million
P/E Ratio
N/A
Dividend Yield
0.53%
Price Target
$140.00
Consensus Rating
Hold

Company Overview

Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries. The Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for inherited genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other differentiated applications for use in research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; PurePep Chorus and Symphony instruments for peptide synthesis; and PurePep EasyClean products for purifying peptides. The Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems, offered under DialyGuard, ViewPoint, DataTrace, DryCal, and BGI brands. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.

Mesa Laboratories Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
52nd Percentile Overall Score

MLAB MarketRank™: 

Mesa Laboratories scored higher than 52% of companies evaluated by MarketBeat, and ranked 626th out of 975 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Mesa Laboratories has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 1 buy rating, no hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    Mesa Laboratories has only been the subject of 1 research reports in the past 90 days.

  • Read more about Mesa Laboratories' stock forecast and price target.
  • Earnings Growth

    Earnings for Mesa Laboratories are expected to grow by 5.82% in the coming year, from $7.39 to $7.82 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Mesa Laboratories is -2.67, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Mesa Laboratories is -2.67, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Mesa Laboratories has a P/B Ratio of 4.52. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Mesa Laboratories' valuation and earnings.
  • Percentage of Shares Shorted

    2.27% of the outstanding shares of Mesa Laboratories have been sold short.
  • Short Interest Ratio / Days to Cover

    Mesa Laboratories has a short interest ratio ("days to cover") of 3.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Mesa Laboratories has recently decreased by 18.11%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Mesa Laboratories has a dividend yield of 0.55%, which is in the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Mesa Laboratories does not have a long track record of dividend growth.

  • Dividend Sustainability

    Based on earnings estimates, Mesa Laboratories will have a dividend payout ratio of 8.18% next year. This indicates that Mesa Laboratories will be able to sustain or increase its dividend.

  • Read more about Mesa Laboratories' dividend.
  • Percentage of Shares Shorted

    2.27% of the outstanding shares of Mesa Laboratories have been sold short.
  • Short Interest Ratio / Days to Cover

    Mesa Laboratories has a short interest ratio ("days to cover") of 3.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Mesa Laboratories has recently decreased by 18.11%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Mesa Laboratories has a news sentiment score of 1.55. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.87 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Mesa Laboratories this week, compared to 2 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Mesa Laboratories insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $473,470.00 in company stock.

  • Percentage Held by Insiders

    Only 4.40% of the stock of Mesa Laboratories is held by insiders.

  • Percentage Held by Institutions

    90.60% of the stock of Mesa Laboratories is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Mesa Laboratories' insider trading history.
Receive MLAB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Mesa Laboratories and its competitors with MarketBeat's FREE daily newsletter.

MLAB Stock News Headlines

Mesa Labs price target lowered to $150 from $160 at Evercore ISI
Mesa Laboratories Reports Robust Q2 FY25 Results
This company will win the AI race
Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally critical role in supporting the most revolutionary technology the world’s ever seen… artificial intelligence. And without it, the entire AI industry would collapse.
Mesa Labs Announces Second Quarter Results
MESA LABS DECLARES QUARTERLY DIVIDEND
See More Headlines

MLAB Stock Analysis - Frequently Asked Questions

Mesa Laboratories' stock was trading at $104.77 on January 1st, 2024. Since then, MLAB stock has increased by 16.2% and is now trading at $121.79.
View the best growth stocks for 2024 here
.

Mesa Laboratories, Inc. (NASDAQ:MLAB) posted its earnings results on Monday, May, 31st. The medical instruments supplier reported $0.74 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.91 by $0.17. The medical instruments supplier had revenue of $37.96 million for the quarter, compared to the consensus estimate of $34.92 million. Mesa Laboratories had a positive trailing twelve-month return on equity of 28.52% and a negative net margin of 107.56%.

Top institutional investors of Mesa Laboratories include Conestoga Capital Advisors LLC (9.78%), Royce & Associates LP (6.42%), State Street Corp (3.94%) and Geneva Capital Management LLC (3.55%). Insiders that own company stock include John Bradley Schmieder, Gary M Owens, Evan Guillemin, John James Sullivan, John Sakys, Shannon Hall and Brian David Archbold.
View institutional ownership trends
.

Shares of MLAB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Mesa Laboratories investors own include American Water Works (AWK), Waste Connections (WCN), AUO (AUOTY), DiamondRock Hospitality (DRH), The RMR Group (RMR), iShares Micro-Cap ETF (IWC) and Triple Flag Precious Metals (TFPM).

Company Calendar

Last Earnings
5/31/2021
Ex-Dividend for 9/16 Dividend
8/30/2024
Dividend Payable
9/16/2024
Ex-Dividend for 12/16 Dividend
11/29/2024
Today
12/03/2024
Dividend Payable
12/16/2024
Next Earnings (Estimated)
2/03/2025
Fiscal Year End
3/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Process control instruments
Sub-Industry
Electronic Equipment & Instruments
Current Symbol
NASDAQ:MLAB
CUSIP
59064R10
Employees
736
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$140.00
High Stock Price Target
$160.00
Low Stock Price Target
$120.00
Potential Upside/Downside
+15.0%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
2 Analysts

Profitability

Net Income
$-254,250,000.00
Net Margins
-107.56%
Pretax Margin
-116.33%

Debt

Sales & Book Value

Annual Sales
$216.19 million
Cash Flow
$60.29 per share
Book Value
$26.95 per share

Miscellaneous

Free Float
5,192,000
Market Cap
$661.32 million
Optionable
Not Optionable
Beta
0.86

Social Links

These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

This page (NASDAQ:MLAB) was last updated on 12/3/2024 by MarketBeat.com Staff
From Our Partners